Rover Diagnostics was founded in 2018 by serial tech entrepreneur Mark Fasciano and Biomedical Engineering Professor Sam Sia, in collaboration with Columbia University. Based in New York City, Rover's primary mission is to bring the latest molecular diagnostics capabilities to the point-of-care at an affordable price. ​​Our multidisciplinary team is composed of highly qualified young talent and industry experts with decades of experience in diagnostic medical device development.
CO-FOUNDER AND CHIEF
SCIENCE ADVISOR
Martha Najib
CHIEF STRATEGY AND COMMERCIAL OFFICER
Mike Turnlund
VP, PRODUCT DEVELOPMENT
Brian Kaplan
VP ENGINEERING AND DEVELOPMENT
Sabin Zarrandikoetxea
R&D ENGINEER,
ENGINEERING MANAGER
Angie Riley
R&D SCIENTIST
Lauren Delgado
LABORATORY TECHNICIAN
Krystin Frederick
LABORATORY TECHNICIAN
Liviu Vlaconi
CONTROLLER
Simon Kang
MECHANICAL ENGINEER
Rebeca Seoane
MECHANICAL ENGINEER
Neil Geoghagen
LABORATORY MANAGER
We work closely with our sister company Rover Labs, which provides us with clinical samples, allowing us to seamlessly continue informing our research and refining our product. Additionaly, Rover Labs gives us a unique advantage by providing a direct insight into the diagnostics services market and teaching us how to best serve our customers.